Cargando…

Corrigendum: Advanced HCC with amplified mesenchymal epithelial transition factor receptor responds well to savolitinib: a case report

Detalles Bibliográficos
Autores principales: Yan, Ningning, Zhang, Ziheng, Guo, Sanxing, Shen, Shujing, Li, Xingya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411721/
https://www.ncbi.nlm.nih.gov/pubmed/37564044
http://dx.doi.org/10.3389/fmed.2023.1256685
_version_ 1785086729468772352
author Yan, Ningning
Zhang, Ziheng
Guo, Sanxing
Shen, Shujing
Li, Xingya
author_facet Yan, Ningning
Zhang, Ziheng
Guo, Sanxing
Shen, Shujing
Li, Xingya
author_sort Yan, Ningning
collection PubMed
description
format Online
Article
Text
id pubmed-10411721
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-104117212023-08-10 Corrigendum: Advanced HCC with amplified mesenchymal epithelial transition factor receptor responds well to savolitinib: a case report Yan, Ningning Zhang, Ziheng Guo, Sanxing Shen, Shujing Li, Xingya Front Med (Lausanne) Medicine Frontiers Media S.A. 2023-07-26 /pmc/articles/PMC10411721/ /pubmed/37564044 http://dx.doi.org/10.3389/fmed.2023.1256685 Text en Copyright © 2023 Yan, Zhang, Guo, Shen and Li. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Yan, Ningning
Zhang, Ziheng
Guo, Sanxing
Shen, Shujing
Li, Xingya
Corrigendum: Advanced HCC with amplified mesenchymal epithelial transition factor receptor responds well to savolitinib: a case report
title Corrigendum: Advanced HCC with amplified mesenchymal epithelial transition factor receptor responds well to savolitinib: a case report
title_full Corrigendum: Advanced HCC with amplified mesenchymal epithelial transition factor receptor responds well to savolitinib: a case report
title_fullStr Corrigendum: Advanced HCC with amplified mesenchymal epithelial transition factor receptor responds well to savolitinib: a case report
title_full_unstemmed Corrigendum: Advanced HCC with amplified mesenchymal epithelial transition factor receptor responds well to savolitinib: a case report
title_short Corrigendum: Advanced HCC with amplified mesenchymal epithelial transition factor receptor responds well to savolitinib: a case report
title_sort corrigendum: advanced hcc with amplified mesenchymal epithelial transition factor receptor responds well to savolitinib: a case report
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411721/
https://www.ncbi.nlm.nih.gov/pubmed/37564044
http://dx.doi.org/10.3389/fmed.2023.1256685
work_keys_str_mv AT yanningning corrigendumadvancedhccwithamplifiedmesenchymalepithelialtransitionfactorreceptorrespondswelltosavolitinibacasereport
AT zhangziheng corrigendumadvancedhccwithamplifiedmesenchymalepithelialtransitionfactorreceptorrespondswelltosavolitinibacasereport
AT guosanxing corrigendumadvancedhccwithamplifiedmesenchymalepithelialtransitionfactorreceptorrespondswelltosavolitinibacasereport
AT shenshujing corrigendumadvancedhccwithamplifiedmesenchymalepithelialtransitionfactorreceptorrespondswelltosavolitinibacasereport
AT lixingya corrigendumadvancedhccwithamplifiedmesenchymalepithelialtransitionfactorreceptorrespondswelltosavolitinibacasereport